Is it safe to operate selected low-risk endometrial cancer patients in secondary hospitals?

被引:0
作者
Narva, Sara [1 ,2 ,7 ,8 ]
Polo-Kantola, Paivi [1 ,2 ]
Oksa, Sinikka [3 ]
Kallio, Johanna [2 ,4 ,7 ]
Huvila, Jutta [2 ,5 ,7 ]
Rissanen, Tiia [2 ,6 ]
Hynninen, Johanna [1 ,2 ,7 ]
Hietanen, Sakari [1 ,2 ,7 ]
Joutsiniemi, Titta [1 ,2 ,7 ]
机构
[1] Turku Univ Hosp, Dept Obstet & Gynecol, Savitehtaankatu 5, Turku 20520, Finland
[2] Univ Turku, Savitehtaankatu 5, Turku 20520, Finland
[3] Satasairaala Hosp, Dept Obstet & Gynecol, Pori, Finland
[4] Turku Univ Hosp, Dept Radiol, Turku, Finland
[5] Turku Univ Hosp, Dept Pathol, Turku, Finland
[6] Turku Univ Hosp, Dept Biostat, Turku, Finland
[7] Org EU Canc Inst, FICAN West, TYKS Canc Ctr, Turku, Finland
[8] Univ Turku, Dept Obstet & Gynecol, Turku Univ Hosp, FIN-20520 Turku, Finland
来源
EJSO | 2024年 / 50卷 / 06期
关键词
Low -risk endometrial cancer; Predictive; Surgery; Centralization; Survival; LYMPH-NODE BIOPSY; LYMPHADENECTOMY; INVASION; GRADE; MRI;
D O I
10.1016/j.ejso.2024.108317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The aim of this study was to assess the accuracy of a preoperative screening algorithm in identifying low-risk endometrial cancer (EC) patients to ensure optimal care. Methods: A total of 277 patients with primary EC confirmed through biopsy underwent magnetic resonance imaging (MRI). Patients with risk factors for advanced high-risk EC, such as non-endometrioid histology, highgrade differentiation status, deep myometrial invasion, or spread beyond the uterine corpus, were systematically excluded. The remaining preoperatively screened patients with stage IA low-grade endometrioid EC (EEC) (n = 93) underwent surgery in a tertiary hospital. The accuracy of the preoperative diagnosis was evaluated by comparing the findings with the postoperative histopathological results. Disease-free survival (DFS) and overall survival (OS) were analyzed using 8-year follow-up data. Results: Postoperative histopathological analysis revealed that all patients had grade 1-2 EEC localized to the corpus uteri. Only three patients had deep myometrial invasion (stage IB), but they remained disease-free after 6-9 years of follow-up. The median follow-up time for all patients was 8.7 years. The DFS was 7.6 years, and the OS was 8.6 years. Two patients with stage IA grade 1 EEC experienced relapse and, despite treatment, died of EC. No other EC-related deaths occurred. Conclusions: The screening algorithm accurately identified low-risk EC patients without compromising survival. Therefore, the algorithm appears to be feasible for selecting patients for surgery in secondary hospitals.
引用
收藏
页数:6
相关论文
共 37 条
  • [21] Cancer of the corpus uteri: 2021 update
    Koskas, Martin
    Amant, Frederic
    Mirza, Mansoor Raza
    Creutzberg, Carien L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 155 : 45 - 60
  • [22] Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy
    Leitao, Mario M., Jr.
    Zhou, Qin C.
    Gomez-Hidalgo, Natalia R.
    Iasonos, Alexia
    Baser, Ray
    Mezzancello, Marissa
    Chang, Kaity
    Ward, Jae
    Chi, Dennis S.
    Roche, Kara Long
    Sonoda, Yukio
    Brown, Carol L.
    Mueller, Jennifer J.
    Gardner, Ginger J.
    Jewell, Elizabeth L.
    Broach, Vance
    Zivanovic, Oliver
    Dowdy, Sean C.
    Mariani, Andrea
    Abu-Rustum, Nadeem R.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 156 (01) : 147 - 153
  • [23] Sentinel lymph node biopsy in endometrial cancer: When, how and in which patients
    Maggiore, Umberto Leone Roberti
    Bascio, Ludovica Spano
    Alboni, Carlo
    Chiarello, Giulia
    Savelli, Luca
    Bogani, Giorgio
    Martinelli, Fabio
    Chiappa, Valentina
    Ditto, Antonino
    Raspagliesi, Francesco
    [J]. EJSO, 2024, 50 (03):
  • [24] Should Endometrial Cancer Treatment Be Centralized?
    Mandato, Vincenzo Dario
    Palicelli, Andrea
    Torricelli, Federica
    Mastrofilippo, Valentina
    Leone, Chiara
    Dicarlo, Vittoria
    Tafuni, Alessandro
    Santandrea, Giacomo
    Annunziata, Gianluca
    Generali, Matteo
    Pirillo, Debora
    Ciarlini, Gino
    Aguzzoli, Lorenzo
    [J]. BIOLOGY-BASEL, 2022, 11 (05):
  • [25] Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary?
    Mariani, A
    Webb, MJ
    Keeney, GL
    Haddock, MG
    Calori, G
    Podratz, KC
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (06) : 1506 - 1516
  • [26] Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer
    Matsuo, Koji
    Klar, Maximilian
    Nusbaum, David J.
    Hasanov, Mir Fuad
    Vallejo, Andrew
    Ciesielski, Katharine M.
    Muderspach, Laila I.
    Roman, Lynda D.
    Wright, Jason D.
    [J]. OBSTETRICS AND GYNECOLOGY, 2022, 139 (05) : 809 - 820
  • [27] Cause-Specific Effects of Radiotherapy and Lymphadenectomy in Stage III Endometrial Cancer: A Population-Based Study
    Mell, Loren K.
    Carmona, Ruben
    Gulaya, Sachin
    Lu, Tina
    Wu, John
    Saenz, Cheryl C.
    Vaida, Florin
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21): : 1656 - 1666
  • [28] Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Oaknin, A.
    Bosse, T. J.
    Creutzberg, C. L.
    Giornelli, G.
    Harter, P.
    Joly, F.
    Lorusso, D.
    Marth, C.
    Makker, V
    Mirza, M. R.
    Ledermann, J. A.
    Colombo, N.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (09) : 860 - 877
  • [29] Accuracy of transvaginal ultrasound versus MRI in the PreOperative Diagnostics of low-grade Endometrial Cancer (PODEC) study: a prospective multicentre study
    Palmer, M.
    Akesson, A.
    Marcickiewicz, J.
    Blank, E.
    Hogstrom, L.
    Torle, M.
    Mateoiu, C.
    Dahm-Kahler, P.
    Leonhardt, H.
    [J]. CLINICAL RADIOLOGY, 2023, 78 (01) : 70 - 79
  • [30] Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
    Panici, Pierluigi Benedetti
    Basile, Stefano
    Maneschi, Francesco
    Lissoni, Andrea Alberto
    Signorelli, Mauro
    Scambia, Giovanni
    Angioli, Roberto
    Tateo, Saverio
    Mangili, Giorgia
    Katsaros, Dionyssios
    Garozzo, Gaetano
    Campagnutta, Elio
    Donadello, Nicoletta
    Greggi, Stefano
    Melpignano, Mauro
    Raspagliesi, Francesco
    Ragni, Nicola
    Cormio, Gennaro
    Grassi, Roberto
    Franchi, Massimo
    Giannarelli, Diana
    Fossati, Roldano
    Torri, Valter
    Amoroso, Mariangela
    Croce, Clara
    Mangioni, Costantino
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (23): : 1707 - 1716